
Longevity Health Holdings, Inc. (NASDAQ: XAGE), relating to the proposed merger with 20/20 BioLabs, Inc. Under the terms of the agreement, Longevity pre-merger stockholders are expected to own approximately 49.9% of the combined company.
Longevity Health Holdings, Inc. (NASDAQ: XAGE), relating to the proposed merger with 20/20 BioLabs, Inc. Under the terms of the agreement, Longevity pre-merger stockholders are expected to own approximately 49.9% of the combined company.